SCHEMBL2807615

SCHEMBL2807615

CCCC[Sn+](CCCC)CCCC.CCCC[Sn+](CCCC)CCCC.O=C([O-])c1ccccc1OS(=O)(=O)O.O=C([O-])c1ccccc1OS(=O)(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
NR1I2 O75469 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRA2A P08913 1/20 0.41
OPRK1 P41145 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
KDM4E B2RXH2 1/20 0.38
RECQL P46063 1/20 0.38
TSHR P16473 4/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
TDP1 Q9NUW8 2/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11308431 1.00 CYP3A4 (0.41) CYP3A4LMNAMEN1KMT2AMAPT
SCHEMBL2807611 0.90 CYP3A4 (0.41) CYP3A4LMNAMEN1KMT2AMAPT
Lithium Ion SCHEMBL10680313 0.81 KDM4E (0.42) MEN1KMT2AMAPTKDM4ETSHR
SCHEMBL10981093 0.81 KDM4E (0.42) MEN1KMT2AMAPTKDM4ETSHR
SCHEMBL2702289 0.81 KDM4E (0.42) MEN1KMT2AMAPTKDM4ETSHR
Potassium Ion SCHEMBL9114094 0.81 KDM4E (0.42) MEN1KMT2AMAPTKDM4ETSHR
SCHEMBL7085287 0.81 KDM4E (0.42) MEN1KMT2AMAPTKDM4ETSHR
SCHEMBL3169148 0.81 KDM4E (0.42) MEN1KMT2AMAPTKDM4ETSHR
SCHEMBL291629 0.81 KDM4E (0.47) MEN1KMT2AMAPTKDM4ETSHR
SCHEMBL20166759 0.81 KDM4E (0.42) MEN1KMT2AMAPTKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4728540-A ABSORPTION FROM SOLUTION CONTAINING PLASTICIZER ARMOR ALL PRODUCTS CORPORATION 1988-03-01 US claimed
EP-2207416-B1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM IMERYS FILTRATION MINERALS INC (US) 2018-11-07 EP disclosed
US-20100239679-A1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM WORLD MINERALS, INC. (US) 2010-09-23 US disclosed
US-20070044729-A1 AMUSEMENT ARTICLES POSSESSING MICROBE-INHIBITING PROPERTIES SEEFAR TECHNOLOGIES, INCORPORATED (US) 2007-03-01 US disclosed
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2006-12-07 US disclosed
US-7137358-B2 Amusement articles possessing microbe-inhibiting properties SEEFAR TECHNOLOGIES, INC. (US) 2006-11-21 US disclosed
US-20010027755-A1 Amusement articles possessing microbe-inhibiting properties ANIMAL MAJESTY, INC. 2001-10-11 US disclosed
US-6240879-B1 Amusement articles possessing microbe-inhibiting properties SEEFAR TECHNOLOGIES, INC. 2001-06-05 US disclosed
US-6196156-B1 Bedding articles possessing microbe-inhibiting properties SEEFAR TECHNOLOGIES, INC. 2001-03-06 US disclosed
US-4728540-A ABSORPTION FROM SOLUTION CONTAINING PLASTICIZER ARMOR ALL PRODUCTS CORPORATION 1988-03-01 US disclosed
US-4284444-A APPLYING BACTERICIDE, FUNGICIDE TO SUBSTRATE ARTICLE HERCULITE PROTECTIVE FABRICS CORPORATION (US) 1981-08-18 US disclosed
US-4219602-A Electrically conductive/antistatic sheeting HERCULITE PROTECTIVE FABRICS CORPORATION (US) 1980-08-26 US disclosed
US-4204018-A ANTISTATIC AGENT CAPABLE OF MIGRATING THROUGHOUT SUBSTRATE HERCULITE PRODUCTS, INC. 1980-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276339-A1 Methods and compositions for increasing the efficacy of biologically-active ingredients ENPP1, ENPP3, SMPD1 CYP3A4 2428/4885LMNA 3199/4885MEN1 1618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.